Being a suppressor, several studies have confirmed that IGFBP3 suppresses cell adhesion [16], invasiveness of endometrial cancer [17], metastasis in prostate cancer [18], and angiogenesis in head and neck squamous cell carcinoma [19]. Here, IGFBP3 is linked to prostate carcinoma.